BIENAIME JEAN JACQUES Insider Trades

Insider Trading History

Track insider trading activity for BIENAIME JEAN JACQUES. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $194k 17,592 shares
Last Trade
Jun 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.2k 1,000 shares
$10.19
$11.03
Immunome
Immunome IMNM
Director
Holding Value $227k 9,897 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 9,897 shares
$18.16
$22.92
Incyte
Incyte INCY
Director
Holding Value $2.81M 24,424 shares
Last Trade
Jun 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$780k 7,753 shares
$100.64
$115.09
Immunome
Immunome IMNM
Director
Holding Value $995k 43,415 shares
Last Trade
Jun 05, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$204k 10,500 shares
$19.45
$22.92
Immunome
Immunome IMNM
Director
Holding Value $984k 42,915 shares
Last Trade
Jun 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$204k 10,500 shares
$19.41
$22.92
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $183k 16,592 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$153k 14,575 shares
$10.50
$11.03
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
Director
Holding Value $242k 900 shares
Last Trade
May 29, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$112k 500 shares
$223.12
$268.57
Incyte
Incyte INCY
Director
Holding Value $4.12M 35,841 shares
Last Trade
May 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.46M 15,000 shares
$97.10
$115.09
Incyte
Incyte INCY
Director
Holding Value $2.62M 22,782 shares
Last Trade
May 26, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.27M 13,059 shares
$97.10
$115.09
Incyte
Incyte INCY
Director
Holding Value $0 0 shares
Last Trade
May 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.46M 15,000 shares
$97.10
$115.09
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
Director
Holding Value $107k 400 shares
Last Trade
May 26, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$95.1k 400 shares
$237.80
$268.57
Immunome
Immunome IMNM
Director
Holding Value $995k 43,415 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$104k 5,000 shares
$20.70
$22.92
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $104k 9,450 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.6k 1,000 shares
$10.58
$11.03
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $93.2k 8,450 shares
Last Trade
Apr 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.7k 1,000 shares
$11.70
$11.03
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
Director
Holding Value $0 0 shares
Last Trade
Mar 23, 2026 Sale
$2M 9,160 shares
$218.06
$268.57
Immunome
Immunome IMNM
Director
Holding Value $880k 38,415 shares
Last Trade
Mar 11, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.6k 1,000 shares
$21.55
$22.92
Immunome
Immunome IMNM
Director
Holding Value $858k 37,415 shares
Last Trade
Mar 10, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.1k 1,000 shares
$22.12
$22.92
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $82.2k 7,450 shares
Last Trade
Mar 09, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.4k 2,000 shares
$11.21
$11.03
Immunome
Immunome IMNM
Director
Holding Value $432k 18,864 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 18,864 shares
$9.57
$22.92
Incyte
Incyte INCY
Director
Holding Value $2.4M 20,841 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$646k 9,216 shares
$70.07
$115.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up